JoVE Logo
Faculty Resource Center

Sign In

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

DOI :

10.3791/62683-v

June 28th, 2021

June 28th, 2021

1,866 Views

1Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, 2Department of Pathology, University of Iowa, 3Department of Chemical and Biological Engineering, College of Engineering, Iowa State University, 4Nanovaccine Institute, Iowa State University, 5Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa, 6Holden Comprehensive Cancer Center, University of Iowa, 7Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa

A standard protocol is described to study the antitumor activity and associated toxicity of IL-1α in a syngeneic mouse model of HNSCC.

Tags

Immunotherapeutic Strategy

-- Views

Related Videos

article

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

article

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

article

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

article

In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment

article

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

article

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

article

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

article

In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts

article

Enhanced Viability for Ex vivo 3D Hydrogel Cultures of Patient-Derived Xenografts in a Perfused Microfluidic Platform

article

In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved